Health4 sources
FDA Scientists Oppose Trump Administration's Effort to Ease Peptides Access
- FDA scientists opposed the Trump administration's effort to ease access to peptides.
- The initiative aimed to allow temporary sales of some unapproved peptides.
- Robert F. Kennedy Jr. advocated for broader use of unapproved peptide injections.
- The proposal faced scrutiny over the safety and efficacy of peptides.
- Multiple news outlets reported on the FDA's stance and the administration's efforts.
Articles (4)
The Guardian·
FDA scientists opposed Trump administration’s move to ease peptide access
ABC News·
FDA scientists opposed the Trump administration's effort to ease peptides access
Associated Press·
FDA scientists opposed the Trump administration’s effort to ease peptides access
Google News·
FDA scientists opposed the Trump administration’s effort to ease peptides access